AIDS

1. PATEL N, Dulion B, Lazcano I, Shi Q, et al
   Antiretroviral-specific associations between bone hormonal changes and treatment induced weight gain.
   AIDS. 2025 Sep 4. doi: 10.1097/QAD.0000000000004330.
   

   >> Share

   
   
2. MATA MARIN JA, Rodriguez Evaristo MS, Cano Diaz AL, Salinas Velazquez GE, et al
   Incidence of Metabolic syndrome in people with HIV without experienCe to antiretroviral Therapy who start doLutegravir based-regimen compared with bictegrAvir based-regimeN after 48 weeks (MICTLAN trial).
   AIDS. 2025 Jun 5. doi: 10.1097/QAD.0000000000004259.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

3. MADLALA HP, Myer L, Geffen H, Jao J, et al
   Maternal Anthropometry, Body Composition, and Fat Distribution by HIV Status and Antiretroviral Therapy Class in South African Women.
   AIDS Res Hum Retroviruses. 2025 Sep 3. doi: 10.1177/08892229251374692.
   

   >> Share

   
   

   
   Clin Infect Dis

4. BECK IA, Boyce CL, Bishop MD, Oldroyd AR, et al
   HIV resistance to dolutegravir varies with co-administered agents.
   Clin Infect Dis. 2025 Sep 2:ciaf481. doi: 10.1093.
   

   >> Share

   
   

   
   HIV Med

5. ORLOVA-MOROZOVA E, Kireev D, Kirichenko A, Bobkov V, et al
   Real-world efficacy of bictegravir/emtricitabine/tenofovir alafenamide regimen in patients infected with HIV-1 sub-subtype A6 harbouring the L74I mutation.
   HIV Med. 2025;26:1463-1467.
   

   >> Share

   
   
6. PIERONE G JR, Brunet L, Fusco JS, Sension MG, et al
   Suppressed switch to Bictegravir/emtricitabine/tenofovir alafenamide compared with dolutegravir/lamivudine: Real-world evidence from the OPERA cohort.
   HIV Med. 2025 Aug 30. doi: 10.1111/hiv.70105.
   

   >> Share

   
   

   
   J Med Virol

7. KIM H, Kim JY, Choi HB, Lee JS, et al
   Antiviral Therapy Reduces Dyslipidemia and Cardiovascular Risk in Chronic Hepatitis B: TDF as the Most Effective Agent.
   J Med Virol. 2025;97:e70584.
   

   >> Share

   
   

   
   PLoS Med

8. SIKOMBE K, Le Tourneau N, Rice B, Pry JM, et al
   Identifying care gaps along the HIV treatment failure cascade: A multistate analysis of viral load monitoring, re-suppression, and regimen switches in Zambia.
   PLoS Med. 2025;22:e1004720.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share